10x Genomics
311 hedge funds and large institutions have $6.29B invested in 10x Genomics in 2022 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 133 increasing their positions, 71 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
311
Holders Change
-51
Holders Change %
-14.09%
% of All Funds
4.92%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.13%
New
50
Increased
133
Reduced
71
Closed
96
Calls
$20.5M
Puts
$31.7M
Net Calls
-$11.2M
Net Calls Change
-$3.96M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$338M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$117M |
| 3 |
BlackRock
New York
|
+$86.6M |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$55.6M |
| 5 |
1WCM
12 West Capital Management
New York
|
+$39.1M |
Top Sellers
| 1 |
DCP
D1 Capital Partners
New York
|
-$239M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$233M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
-$159M |
| 4 |
JCM
JS Capital Management
New York
|
-$80.5M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$59.4M |
